The world congratulation to the research results of injectable cabotegravir is safe and effective in preventing HIV among gay men and other men who have sex with men and transgender women

by Professor Emeritus Praphan Phanuphak, MD Thai version: prevention-trcarc.org “Congratulation” “After I heard announcement the result…

UNAIDS welcomes new tool for HIV prevention for gay men and other men who have sex with men and transgender women

From: UNAIDS Ground-breaking new study shows the efficacy of a long-acting injectable to prevent HIV GENEVA,…

COVID-19: What people with HIV should know

From: CDC Although the risk of serious illness from COVID-19 for people with HIV is not…

Congratulations to our August 2019 PhD graduates

From: Kirby Institute The Kirby Institute would like to congratulate our PhD graduates, Dr Steve Badman…

PERSPECTIVES: Are integrase inhibitors the solution to HIV drug resistance in the Asia-Pacific region?

We asked four regional clinicians, researchers, and policy makers to share their reflections on whether integrase…

Dolutegravir: A Key HIV Drug That Too Many People Cannot Get

The integrase inhibitor dolutegravir (DTG) has shown great promise as a medicine to treat HIV since…

United Nations Under-Secretary-General and UNAIDS Executive Director Michel Sidibé visits her Royal Highness Princess Soamsawali of Thailand at Chulalongkorn Hospital

Bangkok, Thailand, 1 May 2019: United Nations Under-Secretary-General and UNAIDS Executive Director Michel Sidibé who was…

UNAIDS Recognizes the outstanding achievements of The Thai Red Cross AIDS Research Centre in evidence-based innovations

Bangkok, Thailand, 1 May 2019: A high-level event on ‘Advancing innovation in the HIV Response in…

TRCARC’s 30 years of journey to ending AIDS in Thailand

A lookback and ahead 30 years of our journey towards ending AIDS in Thailand

Unlock HIV self-testing kit in Thailand

Food and Drug Administration (FDA) collaborate with Department of Disease Control and Thai Red Cross AIDS…